Searchable abstracts of presentations at key conferences in endocrinology

ea0011p474 | Endocrine tumours and neoplasia | ECE2006

The clinical particularities, medical possibility of prolactonomas in men

Dzeranova LK , Vax VV , Giniatullina EN

The aim of the present investigation was to study first signs of disease, effectiveness of the cabergoline treatment for prolactinomas in men. We studied 53 patients with pituitary adenomas. Patients are divided into 2 groups depending on size of the tumor: group I - microadenomas (11), group II - macroadenomas (42). PRL level before treatment in group I on average was 5890±7.4 mU/l; in group II - 29790±18.2 mU/l. Testosterone level in group I was 9.45±0.6 nmol/...